tiprankstipranks
Trending News
More News >
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market

Insight Molecular Diagnostics (IMDX) Ownership - Who Owns Insight Molecular Diagnostics?

Compare
431 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 11, 2025
xxxxxxxxxxxxx
$200000
Feb 11, 2025
xxxxxxxxxxxxx
$2209080
Feb 10, 2025
xxxxxxxxxxxxx
$10589675
Feb 04, 2025
xxxxxxxxxxxxx
$1839

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
22,820,357Insider79.61%148,788,728
3,258,485Insider11.37%21,245,322
405,554Institution1.41%2,644,212
385,202Institution1.34%2,511,517
201,231Insider0.70%1,312,026
193,433Institution0.67%1,261,183
52,447Insider0.18%341,954
44,378Institution0.15%289,345
39,509Insider0.14%257,599
36,564Insider0.13%238,397

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
385,202Institution1.34%2,511,517
193,433Institution0.67%1,261,183
2,066Institution<0.01%13,470

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
219,885Institution0.77%1,649,138
185,669Institution0.65%1,392,518
28,272Institution0.10%188,857

FAQ

Who Owns Insight Molecular Diagnostics (IMDX)?
Currently, no data Available
What percentage of Insight Molecular Diagnostics (IMDX) stock is held by institutional investors?
Currently, no data Available
What percentage of Insight Molecular Diagnostics (IMDX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Insight Molecular Diagnostics (IMDX)?
Broadwood Partners Lp owns the most shares of Insight Molecular Diagnostics (IMDX).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.